x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

PharmaSource Podcast

Life Science Networks

Welcome to the PharmaSource podcast: the pharma and biotech podcast that explores the latest trends, challenges, and commercial opportunities shaping the biopharma manufacturing and outsourcing. In each episode we"ll be speaking with top executives, researchers, and outsourcing experts, who share their perspectives on topics such as building a smarter, more sustainable supply chain, how to partner with CDMOs, digital transformation, procurement and external manufacturing strategies, and plenty more

science life sciences

All Episodes

00:32:26

CDMO Customer Experience: Lessons from Francisco...

PharmaSource Podcast ·

2025/02/18

Francisco Blanco, founder of Conducta consulting, believes the human element in CDMO-sponsor relationships has been lost in the race for efficiency. “I feel like the human component of these relationships has been lost. When I see five-star client services from CDMOs, it’s typically not because of the strength of their processes – it’s the individual.”Francisco Blanco brings over 15 years of experience from leadership roles at Thermo Fisher and IQVIA to his consultancy Conducta, where he helps life

en

00:21:59

How AustinPx's Solvent-Free Technology Eliminates...

PharmaSource Podcast ·

2025/02/14

"We estimate about 8,000 metric tonnes of solvent per year are used by the industry to support solvent-based spray drying. That's a significant impact on cost, maintenance, safety and the environment," says Elizabeth Hickman, CEO of AustinPx, highlighting a critical sustainability challenge in pharmaceutical manufacturing.Elizabeth Hickman brings extensive experience in pharmaceutical contract manufacturing to her new role as CEO of AustinPx, having worked with several CDMOs and held

en

00:17:01

How Alfasigma’s Morpho is Reshaping CDMO Services for...

PharmaSource Podcast ·

2025/02/11

“We seek long-term partnerships where our technologies can bring genuine value-add that sustains growth. It’s not about geography – it’s about matching specialties and capabilities with companies who share our vision for innovation,” says Rocco Paracchini, Director of CDMO Business Unit Morpho at Alfasigma.Rocco Paracchini brings a blend of a biology background and extensive pharmaceutical manufacturing experience to his role as Director of Morpho at Alfasigma. After transitioning from biotech to

en

00:27:55

How will US pharma manufacturing be reshaped by the...

PharmaSource Podcast ·

2025/02/06

A perfect Storm for US Drug Manufacturing as FDA Changes, Trade Wars and M&A Surge Collide"There's optimism… but the challenges aren't day to day - it can be minute to minute," warns Gil Roth, President of the Pharma and Biopharma Outsourcing Association (PBOA), describing a pharmaceutical manufacturing sector facing unprecedented change in 2025. Gil Roth brings deep expertise in pharmaceutical policy and manufacturing legislation, having launched PBOA in 2014 as an essential

en

00:36:54

From Cars to Cures: What Pharma Can Learn from...

PharmaSource Podcast ·

2025/02/05

“The automotive industry was once in a similar setup to big pharma players, but they evolved through closer supplier collaboration and continuous improvement practices,” says Fabrice Le Garrec, drawing parallels between today’s pharmaceutical manufacturing challenges and the automotive industry’s transformation. “Toyota’s model of developing suppliers as an extension of your company is something pharma isn’t doing enough of.” Fabrice Le Garrec brings extensive pharmaceutical operations experience

en

00:13:21

Cell and Gene Therapy Manufacturing: How 2D Automated...

PharmaSource Podcast ·

2025/01/31

Kolon Biotech's Jungjong Cho believes that the future of cell and gene therapy lies in automation, which offers unprecedented precision and cost efficiencies."Traditional manufacturing is prone to human error and variability among operators, affecting the quality of the product," JJ explains. "To overcome these disadvantages, our robotic manipulator significantly reduces these errors and ensures batch-to-batch consistency." Kolon Biotech is pioneering the use of two

en

00:39:11

Bayer’s Supply Chain Transformation: Why Traditional...

PharmaSource Podcast ·

2025/01/27

“The Americans put a man on the moon in less time than it takes us to transfer a product between countries – this has to change,” says Luiz Barberini, who leads External Manufacturing for Bayer Consumer Health across Latin America.Luiz Barberini combines over three decades of pharmaceutical supply chain expertise from roles at Pfizer, Merck and now Bayer with academic positions at Brazil’s leading business schools. His unique perspective spans both practical implementation and theoretical

en

00:38:39

Netherlands Biotech Ecosystem: Inside Europe's...

PharmaSource Podcast ·

2025/01/23

The Netherlands has emerged as one of Europe's most vibrant and interconnected biotech ecosystems, home to over 1,797 life science companies, world-class pharmaceutical manufacturers, and the European Medicines Agency.With its strategic location, exceptional infrastructure, and collaborative spirit, the country has become known as 'what industry leaders call 'Europe's connected life sciences & health metropolis'. Ahead of CDMO Live 2025, which takes place in Rotterdam's

en

00:37:58

Lipid Nanoparticles (LNPs) Manufacturing Explained:...

PharmaSource Podcast ·

2025/01/16

“The market for lipid nanoparticles really exploded during COVID-19,” says Alexander Aust, LNP manufacturing expert.Alexander Aust, a consultant specialising in lipid nanoparticle (LNP) manufacturing, brings years of experience from companies like Sigma-Tau Pharmaceuticals and Exelead. His expertise spans from commercial liposomal drug products to cutting-edge mRNA and gene editing technologies. In the latest PharmaSource podcast episode, Alexander explains why LNPs have become crucial in drug

en

00:24:24

Johnson & Johnson’s External Manufacturing Digital...

PharmaSource Podcast ·

2025/01/10

The COVID-19 pandemic didn't just disrupt pharmaceutical manufacturing—it catalysed a fundamental shift in how we approach CDMO partnerships. Johnson & Johnson's Paolo Giudici reveals how their four-year digital transformation journey is reshaping the future of external manufacturing.Key transformations reshaping sponsor-CDMO relationships: Real-time manufacturing floor visibility enabling proactive process control Seamless ERP integration across the partner ecosystem Standardised

en

00:41:43

Women in BioPharma [Live] - Breaking the Glass...

PharmaSource Podcast ·

2025/01/02

Leadership insights from our latest Women in BioPharma meetup."I fully expect that the industry will have multiple female CEOs in the years to come," predicts Elizabeth Hickman, Chief Executive Officer of Austin Pharmaceuticals. However, the current state of the pharma industry is that while gender mix starts fairly even, by the time you get to the C-suite, the top table is still overwhelmingly male. In our most recent Women in BioPharma meetup Elizabeth Hickman was joined by Nikki Whitfield, CEO

en

00:22:56

The Promise of Cell & Gene Therapy to Reshape...

PharmaSource Podcast ·

2024/12/20

Gene editing and cell therapy, they’re going to be entrenched modalities, much like small molecules and antibodies are today, that will fundamentally reshape healthcare.” says Devyn Smith.Devyn Smith, CEO of Arbor Biotechnologies and Chairman of the Alliance for Regenerative Medicine, brings a wealth of experience to the cell and gene therapy ecosystem. With a PhD in developmental biology and eight years in strategy consulting, Devyn’s journey led him to Pfizer, where he served as COO of their

en

00:27:39

Alkermes’ 9 KPIs That Drive Successful CDMO Management

PharmaSource Podcast ·

2024/12/15

Stephen Sheehan of Alkermes shares their new governance framework for high-performing CDMO partnerships.As Director of External Development & Manufacturing at Alkermes, Stephen Sheehan brings over a decade of experience in pharmaceutical development, transitioning from small to large molecules, and implementing innovative CDMO management frameworks. Based in Dublin, he’s responsible for managing CDMOs involved in development activities and manufacturing of Alkermes’ drug development

en

00:17:27

How Upperton Pharma Solutions is Redefining CDMO...

PharmaSource Podcast ·

2024/12/12

For us, it’s not a transaction. It really is a partnership,” says Nikki Whitfield, CEO of Upperton Pharma Solutions. Nikki Whitfield brings over three decades of pharmaceutical development experience to her role as CEO of Upperton Pharma Solutions. A chemist by background and self-described “formulator by heart,” she has significant experience developing sterile and non-sterile dosage forms for small and mid-sized pharma companies, including a tenure at Quotient Sciences, before taking the helm at

en

00:43:37

What is a Human-Centric CDMO? In conversation with...

PharmaSource Podcast ·

2024/12/08

Hanns-Christian Mahler, Chief Enablement Officer at ten23 health, is redefining leadership in pharmaceutical manufacturing: “I believe collaboration at the workplace should be primarily based on trust and motivation, not on typical carrot and stick command and control models.” Founded in 2021, ten23 health has a mission to be a human-centric and sustainable strategic partner of the pharmaceutical industry. With extensive experience at companies including Merck, Roche, and Lonza, Hanns-Christian

en

00:16:07

Early-Stage Biotech CDMO Partnering Strategies with...

PharmaSource Podcast ·

2024/12/03

John Childers, Director of Business Development for Wacker Biotech’s North American operations, emphasises the importance of early CDMO partnerships: “Working with an experienced CDMO partner can really help you stay on track for budget and schedule. Think long term – the investment with an external partner can substantially save you time and money.”As part of Wacker Chemie, a century-old German chemical company, the biotech division leverages over 20 years of experience in advanced therapy

en

00:22:04

Pharma's $300bn Revenue Gap: Horizon Scanning with...

PharmaSource Podcast ·

2024/12/01

The pharmaceutical industry faces a significant challenge with patent expiries threatening established revenue streams of approximately $300 Billion USD. Major brands are approaching patent expiry creating urgency for companies to identify new blockbuster opportunities. This is compounded by policy changes like the Inflation Reduction Act, which offers different exclusivity periods for biologics versus small molecules. Adam Siebert and Jeff Holder are partners at L.E.K. Consulting’s life science

en

00:30:03

Be ‘Right First Time’: Lessons for Biotech CMC with...

PharmaSource Podcast ·

2024/11/22

David Caron, Senior Vice-President of CMC, AL102 at Immunome, shares why choosing the right CDMO partner can make or break a biotech’s development timeline: “For biotechs, the main business challenge is to do right the first time. To do this, we need to look at the risks related to each activity.”David Caron brings over three decades of pharmaceutical industry experience across multiple biotechs, with expertise spanning from bench formulation to senior leadership roles. His background includes

en

00:20:54

From Platform to Product Development: Integra...

PharmaSource Podcast ·

2024/11/18

Dr. Avencia Sánchez-Mejías is CEO and co-founder of Integra Therapeutics, a Barcelona-based biotech company developing next-generation gene-editing tools. With a background in molecular biology and clinical genetics, she brings over 15 years of experience in genetic therapy research across Europe, the US, and Asia. In this exclusive interview, Avencia shares insights on transitioning from academia to entrepreneurship, building a sustainable biotech company, and leveraging strategic partnerships to

en

00:37:16

ADC Manufacturing: Are only 5 CDMOs fit for purpose?

PharmaSource Podcast ·

2024/11/13

"The reality is, we have a lot of CDMOs don't they really know what they're getting into" says Herman BozenhardtHerman Bozenhardt, a pharmaceutical manufacturing consultant with decades of experience in facility design and operations, brings a wealth of knowledge from his work with numerous pharmaceutical companies and contract manufacturers. His expertise spans from traditional small molecule drugs to complex biologics and potent compounds. In the latest PharmaSource podcast episode, Herman

en

204 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter